These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10052312)

  • 1. Building a better biotech company.
    Turner L
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE5-6. PubMed ID: 10052312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can science be a business? Lessons from biotech.
    Pisano GP
    Harv Bus Rev; 2006 Oct; 84(10):114-24, 150. PubMed ID: 17040044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotech business Down Under.
    Beckley C
    Nature; 2004 Jun; 429(6991 Suppl):5-9. PubMed ID: 15175704
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech R&D still reeling.
    Lawrence S
    Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth and profitability in small privately held biotech firms: preliminary findings.
    Brännback M; Carsrud A; Renko M; Ostermark R; Aaltonen J; Kiviluoto N
    N Biotechnol; 2009 Jun; 25(5):369-76. PubMed ID: 19491050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Business Ethics 101 for the biotech industry.
    MacDonald C
    BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small company mergers--good for whom?
    Maybeck V; Bains W
    Nat Biotechnol; 2006 Nov; 24(11):1343-8. PubMed ID: 17093475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotechnology's emerging opportunities: lessons from the Bauhaus.
    Scarlett JA
    Nat Biotechnol; 1999 Feb; 17 Suppl():BE13-5. PubMed ID: 10052316
    [No Abstract]   [Full Text] [Related]  

  • 13. Special: biotech in Russia.
    Rabinovich M; Burghardt N; Gorzka G; Kudryashev M; Leonov A; Konov A
    Biotechnol J; 2007 Jul; 2(7):775-89. PubMed ID: 17615597
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology and new companies arising from academia.
    Vallance P
    Lancet; 2001 Nov; 358(9295):1804-6. PubMed ID: 11734259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
    Gruber AC
    Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public biotech 2006 - the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
    [No Abstract]   [Full Text] [Related]  

  • 18. Profiles of four top biotech companies in India.
    Suresh N; Rao ChS
    Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
    [No Abstract]   [Full Text] [Related]  

  • 19. Public biotechnology 2005--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2006 Jun; 24(6):625-34. PubMed ID: 16763588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiotech in big pharma: a business perspective.
    Würmseher M; Firmin L
    Nanomedicine (Lond); 2017 Mar; 12(5):535-543. PubMed ID: 28178881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.